Open-Label Study of ARD-0403 in Testosterone Deficient Men
Status:
Terminated
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
Male hypogonadism, a disorder associated with testosterone deficiency, is frequently seen in
clinical practice and has significant effects on patient well-being. The purpose of this
study is to investigate the efficacy and safety of ARD-0403 as a testosterone replacement
therapy in testosterone deficient men.